Featured

Accelerating Treatments and Access for Patients With Cancer and Immune Disease



Published
MiNK Therapeutics President & CEO Jennifer Buell joins Jill Malandrino on Nasdaq #TradeTalks to discuss accelerating treatments and access for patients with cancer and immune disease.
Category
Health
Be the first to comment